Literature DB >> 22052201

Igf2-derived intronic miR-483 promotes mouse hepatocellular carcinoma cell proliferation.

Ning Ma1, Fuyuan Li, Dan Li, Yang Hui, Xidi Wang, Yu Qiao, Yanfen Zhang, Ying Xiang, Jianying Zhou, Lingyun Zhou, Xiaofei Zheng, Xu Gao.   

Abstract

Most intronic micro-RNAs are coexpressed with their host genes, suggesting that they may play similar roles. The function of miR-483 remains unknown, although it is embedded in an intron of Igf2 gene, which is an activator of hepatocellular carcinoma proliferation. In the present study, we provide evidence that Igf2-derived miR-483 can induce proliferation in hepatocellular carcinoma cells. The miR-483 promotion of proliferation was analysed by soft agar colony formation assay and proliferation curve assay. The effect of miR-483 on Socs3 expression was examined by Western blot and a reporter assay. Our results revealed that Igf2-derived intronic miR-483 was identified by the application of 94G6, an inhibitor of Igf2 at the transcriptional level. All results from the (3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide) MTT assay, the proliferation curve assay and the soft agar colony formation assay showed that miR-483 promoted the proliferation of hepatocellular carcinoma cells. Finally, Socs3, a putative target predicted by bioinformatics, was regulated by miR-483 at mRNA and protein levels. Direct binding with the 3' UTR was identified by a luciferase activity assay. Our findings demonstrate that Igf2-derived intronic miR-483, through downregulation of its target Socs3, regulates hepatoma cell proliferation and thus may serve as a potential target for hepatocellular carcinoma therapy.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22052201     DOI: 10.1007/s11010-011-1121-x

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  28 in total

1.  Identification of bioactive molecules by adipogenesis profiling of organic compounds.

Authors:  Yongmun Choi; Yoshinori Kawazoe; Koji Murakami; Hiroyuki Misawa; Motonari Uesugi
Journal:  J Biol Chem       Date:  2002-12-19       Impact factor: 5.157

2.  Discordant expression of miR-103/7 and pantothenate kinase host genes in mouse.

Authors:  Brenda J Polster; Shawn K Westaway; Thuy M Nguyen; Moon Y Yoon; Susan J Hayflick
Journal:  Mol Genet Metab       Date:  2010-08-04       Impact factor: 4.797

Review 3.  Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight?

Authors:  Witold Filipowicz; Suvendra N Bhattacharyya; Nahum Sonenberg
Journal:  Nat Rev Genet       Date:  2008-02       Impact factor: 53.242

4.  MicroRNA-21 acts as an oncomir through multiple targets in human hepatocellular carcinoma.

Authors:  Changzheng Liu; Jia Yu; Shuangni Yu; Robert M Lavker; Lei Cai; Wei Liu; Kegong Yang; Xiaodong He; Songsen Chen
Journal:  J Hepatol       Date:  2010-04-04       Impact factor: 25.083

5.  MiR-33 contributes to the regulation of cholesterol homeostasis.

Authors:  Katey J Rayner; Yajaira Suárez; Alberto Dávalos; Saj Parathath; Michael L Fitzgerald; Norimasa Tamehiro; Edward A Fisher; Kathryn J Moore; Carlos Fernández-Hernando
Journal:  Science       Date:  2010-05-13       Impact factor: 47.728

6.  MicroRNA profiling of adrenocortical tumors reveals miR-483 as a marker of malignancy.

Authors:  Erin E Patterson; Alisha K Holloway; Julie Weng; Tito Fojo; Electron Kebebew
Journal:  Cancer       Date:  2010-11-08       Impact factor: 6.860

7.  MicroRNA-195 suppresses tumorigenicity and regulates G1/S transition of human hepatocellular carcinoma cells.

Authors:  Teng Xu; Ying Zhu; Yujuan Xiong; Yi-Yuan Ge; Jing-Ping Yun; Shi-Mei Zhuang
Journal:  Hepatology       Date:  2009-07       Impact factor: 17.425

8.  A mammalian microRNA expression atlas based on small RNA library sequencing.

Authors:  Pablo Landgraf; Mirabela Rusu; Robert Sheridan; Alain Sewer; Nicola Iovino; Alexei Aravin; Sébastien Pfeffer; Amanda Rice; Alice O Kamphorst; Markus Landthaler; Carolina Lin; Nicholas D Socci; Leandro Hermida; Valerio Fulci; Sabina Chiaretti; Robin Foà; Julia Schliwka; Uta Fuchs; Astrid Novosel; Roman-Ulrich Müller; Bernhard Schermer; Ute Bissels; Jason Inman; Quang Phan; Minchen Chien; David B Weir; Ruchi Choksi; Gabriella De Vita; Daniela Frezzetti; Hans-Ingo Trompeter; Veit Hornung; Grace Teng; Gunther Hartmann; Miklos Palkovits; Roberto Di Lauro; Peter Wernet; Giuseppe Macino; Charles E Rogler; James W Nagle; Jingyue Ju; F Nina Papavasiliou; Thomas Benzing; Peter Lichter; Wayne Tam; Michael J Brownstein; Andreas Bosio; Arndt Borkhardt; James J Russo; Chris Sander; Mihaela Zavolan; Thomas Tuschl
Journal:  Cell       Date:  2007-06-29       Impact factor: 41.582

9.  Real-time quantification of microRNAs by stem-loop RT-PCR.

Authors:  Caifu Chen; Dana A Ridzon; Adam J Broomer; Zhaohui Zhou; Danny H Lee; Julie T Nguyen; Maura Barbisin; Nan Lan Xu; Vikram R Mahuvakar; Mark R Andersen; Kai Qin Lao; Kenneth J Livak; Karl J Guegler
Journal:  Nucleic Acids Res       Date:  2005-11-27       Impact factor: 16.971

10.  Epigenetic therapy upregulates the tumor suppressor microRNA-126 and its host gene EGFL7 in human cancer cells.

Authors:  Yoshimasa Saito; Jeffrey M Friedman; Yoshitomo Chihara; Gerda Egger; Jody C Chuang; Gangning Liang
Journal:  Biochem Biophys Res Commun       Date:  2008-12-29       Impact factor: 3.322

View more
  7 in total

1.  Increased Intragenic IGF2 Methylation is Associated with Repression of Insulator Activity and Elevated Expression in Serous Ovarian Carcinoma.

Authors:  Zhiqing Huang; Susan K Murphy
Journal:  Front Oncol       Date:  2013-05-24       Impact factor: 6.244

2.  Metformin inhibits tumor growth by regulating multiple miRNAs in human cholangiocarcinoma.

Authors:  Xingming Jiang; Ning Ma; Dayong Wang; Fuyuan Li; Rongzhang He; Dongliang Li; Ruiqi Zhao; Qingxin Zhou; Yimin Wang; Fumin Zhang; Ming Wan; Pengcheng Kang; Xu Gao; Yunfu Cui
Journal:  Oncotarget       Date:  2015-02-20

3.  miR-200a targets Gelsolin: A novel mechanism regulating secretion of microvesicles in hepatocellular carcinoma cells.

Authors:  Ya Xu; Yanfen Zhang; Lujing Wang; Ruiqi Zhao; Yu Qiao; Dong Han; Qian Sun; Nazhen Dong; Yicong Liu; Dantong Wu; Xuemei Zhang; Ning Huang; Ning Ma; Weiming Zhao; Yanhong Liu; Xu Gao
Journal:  Oncol Rep       Date:  2017-03-15       Impact factor: 3.906

4.  Exosomal MicroRNAs as Potential Biomarkers of Hepatic Injury and Kidney Disease in Glycogen Storage Disease Type Ia Patients.

Authors:  Roberta Resaz; Davide Cangelosi; Daniela Segalerba; Martina Morini; Paolo Uva; Maria Carla Bosco; Giuseppe Banderali; Ana Estrella; Corbinian Wanner; David A Weinstein; Annalisa Sechi; Sabrina Paci; Daniela Melis; Maja Di Rocco; Young Mok Lee; Alessandra Eva
Journal:  Int J Mol Sci       Date:  2021-12-28       Impact factor: 5.923

5.  Overexpression of miR-483-5p/3p cooperate to inhibit mouse liver fibrosis by suppressing the TGF-β stimulated HSCs in transgenic mice.

Authors:  Fuyuan Li; Ning Ma; Ruiqi Zhao; Guodong Wu; Yanfen Zhang; Yu Qiao; Dong Han; Ya Xu; Ying Xiang; Bingzhu Yan; Jianfeng Jin; Guixiang Lv; Lei Wang; Changqing Xu; Xu Gao; Shanshun Luo
Journal:  J Cell Mol Med       Date:  2014-05-06       Impact factor: 5.310

6.  The IGF2 intronic miR-483 selectively enhances transcription from IGF2 fetal promoters and enhances tumorigenesis.

Authors:  Mingzhu Liu; Anna Roth; Min Yu; Robert Morris; Francesca Bersani; Miguel N Rivera; Jun Lu; Toshihiro Shioda; Shobha Vasudevan; Sridhar Ramaswamy; Shyamala Maheswaran; Sven Diederichs; Daniel A Haber
Journal:  Genes Dev       Date:  2013-12-01       Impact factor: 11.361

Review 7.  The GH-IGF-SST system in hepatocellular carcinoma: biological and molecular pathogenetic mechanisms and therapeutic targets.

Authors:  Claudia Pivonello; Maria Cristina De Martino; Mariarosaria Negri; Gaia Cuomo; Federica Cariati; Francesco Izzo; Annamaria Colao; Rosario Pivonello
Journal:  Infect Agent Cancer       Date:  2014-08-20       Impact factor: 2.965

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.